门诊癌症患者呼吸道症状与体能状态对不可疑肺栓塞的预后价值
本研究基于国际前瞻性观察性UPE注册队列,纳入695例门诊癌症患者,评估呼吸道症状和ECOG体能状态对30、90、180天死亡率及总生存的预测价值,并应用于Hull临床预测规则。结果显示,患者报告的14天内呼吸道症状和UPE诊断时的ECOG体能状态是最一致的死亡预测因素,应用于Hull-CPR后与近期死亡率和总生存呈一致相关性。
要点
- UPE诊断前14天内患者报告的呼吸道症状和诊断时ECOG体能状态可分层死亡风险。
- 将上述预测因素应用于Hull-CPR,与30、90、180天死亡率及总生存一致相关。
- Hull-CPR结合这些因素可确认低-中危和高危风险分层簇。
核心结论
- 在门诊癌症合并不可疑肺栓塞患者中,UPE诊断时同期记录的ECOG体能状态和诊断前呼吸道症状可分层死亡风险。
研究设计与样本
- 国际前瞻性观察性UPE注册队列研究,纳入695例门诊癌症患者,采用多变量logistic回归分析识别与近期死亡率和总生存独立相关的预测因素。
主要发现
- 最一致的死亡预测因素为患者报告的UPE诊断前14天内呼吸道症状和UPE诊断时ECOG体能状态。
- 应用于Hull-CPR后确认了原始推导队列中见到的低-中危和高危风险分层簇。
临床怎么用
- 在门诊癌症患者中,可依据UPE诊断时ECOG体能状态和诊断前14天内呼吸道症状评估死亡风险。
- 可将上述因素应用于Hull-CPR以辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimal risk stratification of unsuspected pulmonary embolism (UPE) in ambulatory cancer patients (ACPs) remains unclear. Existing clinical predictive rules (CPRs) are derived from retrospective databases and have limitations. The UPE registry is a prospective international registry with pre-specified characteristics of ACPs with a recent UPE. The aim of this study was to assess the utility of risk factors captured in the UPE registry in predicting proximate (30-, 90- and 180-day) mortality and how they performed when applied to an existing CPR. OBJECTIVES: To evaluate risk factors for proximate mortality, overall survival, recurrent venous thromboembolism and major bleeding, in the patients enrolled in the UPE registry cohort. METHODS: Data from the 695 ACPs in this registry were subjected to multivariate logistic regression analyses to identify predictors independently associated with proximate mortality and overall survival. The most consistent predictors were applied to the Hull CPR, an existing 5-point prediction rule. RESULTS: The most consistent predictors of mortality were patient-reported respiratory symptoms within 14 days before, and ECOG performance status at the time of UPE. These predictors applied to the Hull-CPR produced a consistent correlation with proximate mortality and overall survival (area under the curve [AUC] = 0.70 [95% CI 0.63, 077], AUC = 0.65 [95% CI 0.60, 070], AUC = 0.64 [95% CI 0.59, 068], and AUC = 0.61, 95% CI 0.57, 0.65, respectively). CONCLUSION: In ACPs with UPE, ECOG performance status logged contemporaneously to the UPE diagnosis and respiratory symptoms prior to UPE diagnosis can stratify mortality risk. When applied to the HULL-CPR these risk predictors confirmed the risk stratification clusters of low-intermediate and high-risk for proximate mortality as seen in the original derivation cohort.
引用
- Maraveyas A, Kraaijpoel N, Bozas G, et al. The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study. J Thromb Haemost. 2021. PMID: 34532927. doi:10.1111/jth.15489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。